Federal health officials allowed a genetic-testing firm to sell kits to consumers to test whether they carry gene mutations that put them at higher risk for breast and ovarian cancer, a move that is part of a broader regulatory shift.
from WSJ.com: US Business http://ift.tt/2FqdyhJ
via IFTTT
No comments:
Post a Comment